SuperValu Whistleblowers Seek SCOTUS Review of Drug Pricing Suit - Bloomberg Law
Two whistleblowers urged the U.S. Supreme Court to revive their False Claims Act suit against SuperValu Inc. alleging that it overcharged federal healthcare programs for prescription drugs. The U...
Read more